Testing effectiveness (Phase 2)WithdrawnNCT04535102What this trial is testingPOLA+BR for Relapsed or Refractory DLBCLWho this might be right forDiffuse Large B Cell Lymphoma University of Colorado, Denver
Testing effectiveness (Phase 2)Temporarily pausedNCT04855253What this trial is testingPh I/II Study of E7777 Prior to CAR-T for R/R LBCLWho this might be right forDLBCLDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more Masonic Cancer Center, University of Minnesota 30
Not applicableStudy completedNCT04872621What this trial is testingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma) AstraZeneca 104
Early research (Phase 1)Ended earlyNCT03704298What this trial is testingSafety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell LymphomaWho this might be right forRelapsed/Refractory Large B-cell Lymphoma Kite, A Gilead Company 15
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Not applicableStudy completedNCT00281814What this trial is testingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 36
Large-scale testing (Phase 3)Looking for participantsNCT07516093What this trial is testingStudy of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLWho this might be right forB-cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Nurix Therapeutics, Inc. 620
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Very early researchEnded earlyNCT04034446What this trial is testingCD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia Institute of Hematology & Blood Diseases Hospital, China 2
Large-scale testing (Phase 3)Study completedNCT03476239What this trial is testingEfficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen 121
Testing effectiveness (Phase 2)UnknownNCT01354457What this trial is testingSafety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+Who this might be right forAcute Lymphoblastic Leukemia Nantes University Hospital 21
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Early research (Phase 1)Ended earlyNCT02082977What this trial is testingInvestigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple MyelomaWho this might be right forCancerNeoplasms GlaxoSmithKline 41
Early research (Phase 1)Looking for participantsNCT06313957What this trial is testingLUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma Peking University Cancer Hospital & Institute 42
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT03820596What this trial is testingSintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCLWho this might be right forSafety and Efficacy Huiqiang Huang 40
Testing effectiveness (Phase 2)Looking for participantsNCT05643742What this trial is testingA Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell MalignanciesWho this might be right forB-cell LymphomaNon-Hodgkin LymphomaB-cell Malignancy+5 more CRISPR Therapeutics AG 120
Early research (Phase 1)Ended earlyNCT02702141What this trial is testingA Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin LymphomaDLBCLDiffuse Large B-cell Lymphoma+1 more Seagen Inc. 44
Testing effectiveness (Phase 2)Study completedNCT04438005What this trial is testingICP-022 in Patients With R/R DLBCLWho this might be right forDiffuse Large B Cell Lymphoma Beijing InnoCare Pharma Tech Co., Ltd. 3